Comprehensive review outlines current non-surgical hair restoration techniques, emphasizing emerging peptide and exosome therapies.

Hair loss, particularly androgenetic alopecia (AGA), is a highly prevalent condition characterized by progressive follicular miniaturization and a shortened anagen phase. While traditional therapies like topical minoxidil and oral finasteride offer variable efficacy, there's a growing demand for non-surgical options, especially for "prejuvenation"—proactive measures to maintain hair health and delay loss. Understanding hair follicle cycling, regulated by dermal papilla signaling and epithelial stem cells, is crucial for developing targeted interventions that address the complex interplay of genetic, hormonal, and environmental factors.

This review article systematically evaluates contemporary non-surgical hair restoration modalities. It covers historical aspects of therapeutic strategies, the underlying hair follicle anatomy and biology, and a wide array of technologies. The authors discuss various interventions, including oral and topical pharmacologics, hormonal therapies, platelet-rich plasma (PRP), microneedling, peptide-based treatments, exosomes, nutraceuticals, and device-based approaches like low-level laser therapy (LLLT). The review also addresses appropriate patient selection for conditions like androgenetic alopecia and other non-scarring alopecias, emphasizing the importance of accurate diagnosis and the increasing utilization of combination therapy.

The review synthesizes that non-surgical therapies for hair loss have evolved significantly, moving from broad-spectrum topical vasodilators to more targeted interventions. It highlights that current strategies encompass a wide array of approaches, including oral and topical pharmacologics, hormonal therapies, and regenerative methods such as platelet-rich plasma (PRP) and microneedling. Furthermore, the authors emphasize the growing importance of emerging technologies, specifically peptide-based treatments and exosomes, alongside nutraceuticals and various light/laser therapies like low-level laser therapy (LLLT). The abstract underscores that combination therapy is increasingly favored to address multiple biological pathways involved in follicular miniaturization and hair follicle cycling. While specific efficacy percentages or p-values are not provided in the abstract, the overarching finding is that:

Non-surgical modalities are central to prejuvenation and can effectively delay or complement surgical intervention when appropriately applied. This comprehensive approach aims to optimize patient outcomes by targeting the complex interplay of dermal papilla signaling, epithelial stem cells, and the perifollicular environment.